| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.839 | 23.220 | 21.809 | 18.816 | 20.117 | 22.061 | 28.385 | 28.228 | 26.113 |
| Total Income - EUR | - | 13.839 | 23.221 | 21.809 | 18.816 | 20.117 | 22.061 | 28.554 | 41.901 | 28.339 |
| Total Expenses - EUR | - | 7.113 | 9.783 | 7.287 | 8.496 | 8.956 | 15.691 | 18.921 | 27.502 | 26.464 |
| Gross Profit/Loss - EUR | - | 6.726 | 13.438 | 14.522 | 10.320 | 11.160 | 6.370 | 9.633 | 14.399 | 1.875 |
| Net Profit/Loss - EUR | - | 6.311 | 12.741 | 13.868 | 9.755 | 10.603 | 5.708 | 8.781 | 13.986 | 1.140 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Gammedgyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 10.746 | 8.043 | 15.208 | 20.618 | 21.997 | 19.132 | 18.666 | 60.644 | 51.456 |
| Current Assets | - | 5.617 | 10.888 | 17.533 | 24.229 | 23.004 | 31.157 | 42.779 | 49.780 | 37.043 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.722 | 2.440 | 543 | 1.011 | 3.555 | 3.812 | 4.449 | 27.689 | 24.338 |
| Cash | - | 3.895 | 8.447 | 16.990 | 23.218 | 19.449 | 27.346 | 38.331 | 22.090 | 12.705 |
| Shareholders Funds | - | 6.355 | 18.657 | 13.919 | 23.405 | 33.564 | 38.528 | 8.836 | 22.851 | 23.863 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 10.008 | 274 | 18.822 | 21.442 | 18.259 | 18.433 | 59.301 | 94.245 | 63.863 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 773 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gammedgyn Srl